Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy

Targeting Peptide, Fluorescent Reagent Modified Magnetic Liposomes Coated with Rapamycin Target Early Atherosclerotic Plaque and Therapy

Atherosclerosis is the leading cause of global morbidity and mortality. Its therapy requires research in several areas, such as diagnosis of early arteriosclerosis, improvement of the pharmacokinetics and bioavailability of rapamycin as its therapeutic agents. Here, we used the targeting peptide VHP...

Full description

Bibliographic Details
Main Authors: Chen Huang, Wentao Huang, Lifen Zhang, Chunyu Zhang, Chengqian Zhou, Wei Wei, Yongsheng Li, Quan Zhou, Wenli Chen, Yukuan Tang
Format: Article
Language:English
Published: MDPI AG 2022-05-01
Series:Pharmaceutics
Subjects:
early atherosclerosis
VCAM-1
MRI
rapamycin
bimodal imaging
Rap/Fe<sub>3</sub>O<sub>4</sub>@VHP-Lipo
Online Access:https://www.mdpi.com/1999-4923/14/5/1083

Internet

https://www.mdpi.com/1999-4923/14/5/1083

Similar Items